Structures by: Neidle S.
Total: 22
C12H16BrN3O2S
C12H16BrN3O2S
Journal of medicinal chemistry (2012) 55, 4 1731-1750
a=10.18411(14)Å b=14.96067(18)Å c=9.13052(13)Å
α=90.00° β=99.2862(14)° γ=90.00°
K4 (Pt2 H8 P8 O20) (H2 O)2
H12K4O22P8Pt2
Journal of the Chemical Society. Chemical Communications (1972-) (1980) 1980, 13-15
a=13.335Å b=13.335Å c=7.989Å
α=90° β=90° γ=90°
C18H12N4O,CH2Cl2,H2O
C18H12N4O,CH2Cl2,H2O
Dalton Transactions (2009) 14 2558-2568
a=9.0384(3)Å b=9.2870(3)Å c=10.8833(3)Å
α=95.453(2)° β=96.174(2)° γ=97.0910(10)°
C34H22N10O4Pd2
C34H22N10O4Pd2
Dalton Transactions (2009) 14 2558-2568
a=18.1469(4)Å b=8.8803(2)Å c=19.3940(6)Å
α=90.00° β=95.9360(10)° γ=90.00°
C23H23N3O4,H2O
C23H23N3O4,H2O
Dalton Transactions (2009) 14 2558-2568
a=9.24730(10)Å b=9.24730(10)Å c=23.1554(9)Å
α=90.00° β=90.00° γ=90.00°
C36H24N10O2Pt2,Cl2,(C2H6OS),(C3H6O),3.75(H2O)
C36H24N10O2Pt2,Cl2,(C2H6OS),(C3H6O),3.75(H2O)
Dalton Transactions (2009) 14 2558-2568
a=17.3137(15)Å b=11.0617(7)Å c=24.561(2)Å
α=90.00° β=104.763(3)° γ=90.00°
C9H12N4O2
C9H12N4O2
Acta Crystallographica Section B (1992) 48, 2 213-217
a=4.933(2)Å b=9.4090(10)Å c=22.865(4)Å
α=90° β=94.16(2)° γ=90°
C8H10N4O2
C8H10N4O2
Acta Crystallographica Section B (1992) 48, 2 213-217
a=5.9660(10)Å b=7.6810(10)Å c=10.4830(10)Å
α=103.290(10)° β=93.080(10)° γ=94.610(10)°
(11aS)-1,2,3,10,11,11a-Hexahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11-dione dihydrate
C12H12N2O2,2(H2O)
Acta Crystallographica Section C (1991) 47, 12 2678-2680
a=8.717(2)Å b=6.9270(10)Å c=10.950(2)Å
α=90° β=113.01(2)° γ=90°
\ (2R,11aS)-2,8-Diacetoxy-7-methoxy-1,2,3,10,11,11a-hexahydro-5H-\ pyrrolo[2,1-c][1,4]benzodiazepine-5,11-dione
C17H18N2O7
Acta Crystallographica Section C (1991) 47, 12 2678-2680
a=6.6330(10)Å b=13.435(2)Å c=19.246(2)Å
α=90° β=90° γ=90°
None
C10H13N3O6
Acta Crystallographica Section C (1996) 52, 12 3173-3177
a=5.5880(10)Å b=11.6450(10)Å c=18.561(2)Å
α=90.00° β=97.560(10)° γ=90.00°
None
C13H19N3O7
Acta Crystallographica Section C (1996) 52, 12 3173-3177
a=15.746(2)Å b=9.3730(10)Å c=11.304(2)Å
α=90.00° β=100.190(10)° γ=90.00°
C18H19NO2S
C18H19NO2S
Acta Crystallographica Section C (1991) 47, 11 2511-2513
a=11.503(3)Å b=15.932(2)Å c=9.133(2)Å
α=90° β=102.17(2)° γ=90°
C19H21NO3S
C19H21NO3S
Acta Crystallographica Section C (1991) 47, 11 2511-2513
a=9.873(2)Å b=13.163(3)Å c=14.065(3)Å
α=101.33(3)° β=94.30(3)° γ=91.35(3)°
C21H27N2,H1Cl1,H2O1
C21H27N2,H1Cl1,H2O1
Acta Crystallographica Section C (1992) 48, 1 188-190
a=11.086(2)Å b=11.086(2)Å c=14.367(4)Å
α=90.00000° β=90.00000° γ=120.00000°
JM216
C10H22Cl2N2O4Pt
Acta Crystallographica Section C (1995) 51, 5 822-824
a=13.588(2)Å b=8.2860(10)Å c=14.683(2)Å
α=90.00° β=110.510(10)° γ=90.00°
C6H9O7P
C6H9O7P
Acta Crystallographica Section C (1998) 54, 8 1191-1192
a=9.2892(6)Å b=9.0724(5)Å c=9.5328(12)Å
α=90.00° β=96.150(6)° γ=90.00°
4-amino-1-(2-deoxy-β-D-ribofuranosyl)-5,6,7-1H- cyclopentapyridine-2-one
C12H17N3O4
Acta Crystallographica Section C (1996) 52, 9 2332-2334
a=9.543(4)Å b=10.2790(10)Å c=12.231(5)Å
α=90.00° β=90.00° γ=90.00°
2-bromo-5-(α-D-2-deoxyribofuranosyl)pyridine
C10H12BrNO3
Acta Crystallographica Section C (1996) 52, 2 407-409
a=7.686(3)Å b=7.2420(10)Å c=9.9240(10)Å
α=90.00° β=98.31(2)° γ=90.00°
C20H18N2NiO6
C20H18N2NiO6
Inorganic Chemistry (2008) 47, 11910-11919
a=10.8940(5)Å b=17.6520(8)Å c=9.0521(4)Å
α=90.00° β=101.2860(10)° γ=90.00°
C20H21N2O7.5Zn
C20H21N2O7.5Zn
Inorganic Chemistry (2008) 47, 11910-11919
a=19.0583(10)Å b=19.0583(10)Å c=4.9557(6)Å
α=90.00° β=90.00° γ=120.00°
C43H49.5FN4NiO4
C43H49.5FN4NiO4
Inorganic Chemistry (2008) 47, 11910-11919
a=26.765(4)Å b=31.067(4)Å c=9.5837(13)Å
α=90.00° β=90.00° γ=90.00°